We generated CHO-S cells expressing GPI-anchored RBD-GM-CSF fusion protein and GPI-IL-12, purified the proteins and incorporated them onto influenza VLPs to develop the hybrid vaccine. This evidence concerns the gene CSF2 and influenza.